January 08 2018
On October 26 2017 the federal minister of health submitted the Patented Medicine Prices Review Board (PMPRB) Annual Report 2016 to the House of Commons and the Senate. The report indicates that in 2016:
As of March 31 2017, 101 investigations into possible excessive patented drug pricing were ongoing.
For further information on this topic please contact Andrew Mandlsohn at Smart & Biggar/Fetherstonhaugh by telephone (+1 416 593 5514) or email (email@example.com). The Smart & Biggar/Fetherstonhaugh website can be accessed at www.smart-biggar.ca.
The materials contained on this website are for general information purposes only and are subject to the disclaimer.
ILO is a premium online legal update service for major companies and law firms worldwide. In-house corporate counsel and other users of legal services, as well as law firm partners, qualify for a free subscription.